A nurse is assessing a 55-year-old client who has been diagnosed with ocular melanoma. Which assessment finding would be most significant for the nurse to document?

Clinical Context and Priority Assessment

For a client diagnosed with ocular melanoma, the nurse's assessment must prioritize findings that indicate potential tumor progression, metastasis, or direct threat to vision and life. While comfort-focused symptoms are important for quality of life, the most significant finding to document is one that signals a change in the underlying disease pathology.

Analysis of the Correct Answer

Progressive vision loss with visual field defects is the most significant finding. Uveal melanoma, the most common primary intraocular cancer in adults, can directly invade the retina and optic nerve, leading to progressive, irreversible vision loss. More critically, the development of new or worsening visual field defects can indicate tumor growth, retinal detachment, or secondary glaucoma, all of which are direct complications of the intraocular mass. From a systemic perspective, this finding is a red flag for potential metastasis, as uveal melanoma has a high propensity for hematogenous spread, particularly to the liver. The provided research underscores that uveal melanoma is characterized by genetic variations, such as BAP1 aberrations, which are strongly associated with metastasis-related mortality ^[2]. A change in visual function may be the first clinical sign of a tumor that is evolving and acquiring these high-risk genomic features. Documenting this finding is crucial for prompting urgent ophthalmologic re-evaluation and staging for metastatic disease.

Why Other Options Are Less Significant

• Option 1: A complaint of mild eye irritation and tearing is a non-specific symptom. While it may be related to a superficial tumor location or secondary dry eye, it does not directly indicate tumor invasion, growth, or metastatic potential. It is a comfort and safety concern but is not the highest priority for documentation related to the cancer's trajectory.


• Option 2: A report of occasional headaches in the morning is a vague symptom that could have numerous benign etiologies. While it theoretically could be a sign of increased intraocular pressure or, very rarely, central nervous system metastasis, it lacks the specificity and direct link to the primary ocular pathology that progressive vision loss provides.


• Option 3: The presence of conjunctival redness and discharge is more indicative of an infectious or inflammatory conjunctival process, not a choroidal or uveal melanoma. It is important to note that inflammation can occur in the context of treated melanoma, as seen with pembrolizumab-associated choroidal inflammation in a patient with a history of treated choroidal melanoma . However, in a client with a current, active diagnosis, a new, progressive visual field defect is a more direct and alarming sign of the primary disease itself than a presentation that mimics conjunctivitis.

Pathophysiology and Clinical Reasoning Synthesis

The clinical priority is grounded in the pathophysiology of uveal melanoma. This malignancy arises from melanocytes in the choroid, ciliary body, or iris. As the tumor enlarges, it can cause serous retinal detachment, directly compress photoreceptors, or invade the optic nerve, all of which manifest as progressive vision loss and visual field defects. The genomic landscape of these tumors, including the identification of novel metastatic markers like BAP1 aberrations, explains their aggressive potential ^[2]. Therefore, when a nurse detects a change in visual function, it is not merely an ocular symptom; it is a potential harbinger of a tumor that is progressing locally and may be acquiring the capacity for lethal systemic spread. This assessment finding directly informs the need for immediate diagnostic imaging and a metastatic workup, making it the most significant item to document.